Immune Response After Inactivated Oral Cholera Vaccine (Dukoral) in Renal Transplant Recipients

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cholera vaccine inactivated (Primary)
Indications Cholera
Focus Pharmacodynamics
Acronyms MICH

Most Recent Events

24 Apr 2019 Status changed to discontinued due slow recruitment when 15 renal transplant recipients (RTR) were included in the P/CNI and P/MMF study arm, according to results published in the Vaccine Journal.
24 Apr 2019 According to results published in the Vaccine Journal, Crucell Holland B.V. is currently known as Johnsson and Johnsson.
24 Apr 2019 Results published in the Vaccine Journal.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight